Vie Ventures

Built for the nextgeneration ofautoimmune therapeutics.

Vie Ventures is a specialist biotechnology investment firm focused on autoimmune and immune-mediated therapeutics. We combine market-rate venture investing, embedded immunology expertise, and disease-focused relationships to help promising therapies advance toward clinical proof of concept.

Our approach

Vie invests primarily in advanced-preclinical through Phase 2 therapeutic opportunities, with selective company creation, seed and other investments. We evaluate mechanisms across diseases, invest around meaningful development milestones, and seek to lead or co-lead financings where appropriate, with capital reserved for follow-on support. Strategic Collaborators provide disease insight and patient perspective; Vie retains investment responsibility and allocation discretion.

Shared immune biology

Related immune pathways can connect therapeutic opportunities across diseases.

Multi-indication potential

Evidence in one disease may inform development in others, with each indication evaluated on its own merits.

Specialist investment execution

Scientific underwriting, financing discipline and development milestones guide investment decisions.

Disease-community insight

Independent Strategic Collaborators contribute disease expertise and patient perspective.

The Vie model

From scientific insight to therapeutic progress.

Specialist biotechnology investing

Scientific underwriting, venture experience and financing discipline.

Disease-community insight

Independent disease expertise, patient perspective and scientific relationships.

Vie Ventures

Investment judgment and execution.

Stage 011

Evaluate the
science

Assess therapeutic mechanisms across diseases, evaluating each opportunity on its own merits.

Stage 022

Invest with discipline

Invest around meaningful development milestones, with capital reserved for follow-on support.

Stage 033

Support development

Help promising therapies advance toward clinical proof of concept.

Advancing the next generation of autoimmune therapeutics.

Building the future of autoimmune therapeutics.

Whether you are a prospective investor, a strategic collaborator, or a company creating next-generation therapies, we would be glad to connect.

Or email us directly at contact@vieventures.com.